Amyloid Precursor Protein Trafficking, Processing, and Function

Intracellular trafficking and proteolytic processing of amyloid precursor protein (APP) have been the focus of numerous investigations over the past two decades. APP is the precursor to the amyloid β-protein (Aβ), the 38–43-amino acid residue peptide that is at the heart of the amyloid cascade hypot...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 283; no. 44; pp. 29615 - 29619
Main Authors Thinakaran, Gopal, Koo, Edward H.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 31.10.2008
American Society for Biochemistry and Molecular Biology
Subjects
Alzheimer Disease - metabolism
Amino Acid Sequence
Amino Acids - chemistry
Amyloid - chemistry
Amyloid Precursor Protein Secretases - metabolism
Animals
Biological Transport
Brain - metabolism
Cell Adhesion
Endocytosis
Humans
Minireviews
Models, Biological
Molecular Sequence Data
Protein Structure, Tertiary
Protein Transport
Online AccessGet full text

Cover

More Information
Summary:Intracellular trafficking and proteolytic processing of amyloid precursor protein (APP) have been the focus of numerous investigations over the past two decades. APP is the precursor to the amyloid β-protein (Aβ), the 38–43-amino acid residue peptide that is at the heart of the amyloid cascade hypothesis of Alzheimer disease (AD). Tremendous progress has been made since the initial identification of Aβ as the principal component of brain senile plaques of individuals with AD. Specifically, molecular characterization of the secretases involved in Aβ production has facilitated cell biological investigations on APP processing and advanced efforts to model AD pathogenesis in animal models. This minireview summarizes salient features of APP trafficking and amyloidogenic processing and discusses the putative biological functions of APP.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
To whom correspondence may be addressed. E-mail: gopal@uchicago.edu. 2 To whom correspondence may be addressed. E-mail: edkoo@ucsd.edu.
This work was supported, in whole or in part, by National Institutes of Health Grants AG019070 and AG021495 (to G. T.) and AG12376 and AG032179 (to E. H. K.) from NIA. This work was also supported by the American Health Assistance Foundation Alzheimer's Disease Research Program and the Alzheimer's Association (to G. T.) and by the Glenn Foundation for Medical Research (to E. H. K.). This is the first article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.R800019200